Peipei Shi

932 total citations · 1 hit paper
36 papers, 396 citations indexed

About

Peipei Shi is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Nephrology. According to data from OpenAlex, Peipei Shi has authored 36 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 10 papers in Nephrology. Recurrent topics in Peipei Shi's work include Renal Diseases and Glomerulopathies (9 papers), Bone health and osteoporosis research (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). Peipei Shi is often cited by papers focused on Renal Diseases and Glomerulopathies (9 papers), Bone health and osteoporosis research (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). Peipei Shi collaborates with scholars based in China, United States and Germany. Peipei Shi's co-authors include Jonathan W. Goldman, Jianjiang Zhang, Martin Reck, Karla Hurt, Luis Paz‐Ares, Andrew Koustenis, Jian Z. Wang, Scott P. Myrand, Na Zeng and Nilendu Gupta and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The FASEB Journal.

In The Last Decade

Peipei Shi

31 papers receiving 392 citations

Hit Papers

Prevalence and risk factor for long COVID in children and... 2023 2026 2024 2025 2023 20 40 60
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prevalence and risk factor for long COVID in children and adolescents: A meta-analysis and systematic review
    2023 72 citations Yongbo Zheng, Na Zeng et al. Journal of Infection and Public Health profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peipei Shi China 12 156 112 88 58 58 36 396
Anne‐Marie Langevin United States 12 103 0.7× 133 1.2× 113 1.3× 43 0.7× 64 1.1× 29 518
Márta Hegyi Hungary 11 116 0.7× 57 0.5× 143 1.6× 31 0.5× 40 0.7× 15 432
Munveer S. Bhangoo United States 12 195 1.3× 164 1.5× 162 1.8× 48 0.8× 110 1.9× 27 563
Lei Dong China 12 145 0.9× 125 1.1× 196 2.2× 29 0.5× 72 1.2× 57 470
Giulia Ferrarazzo Italy 12 41 0.3× 182 1.6× 109 1.2× 56 1.0× 71 1.2× 25 525
Reo Tanoshima Japan 13 85 0.5× 41 0.4× 65 0.7× 27 0.5× 17 0.3× 40 456
Janet Yoon United States 9 118 0.8× 64 0.6× 133 1.5× 53 0.9× 93 1.6× 23 381
Kentaro Tsunamoto Japan 10 139 0.9× 21 0.2× 62 0.7× 124 2.1× 62 1.1× 26 514
Raees Tonse India 10 58 0.4× 115 1.0× 95 1.1× 27 0.5× 31 0.5× 39 292
Longkai Peng China 15 182 1.2× 66 0.6× 51 0.6× 13 0.2× 107 1.8× 52 437

Countries citing papers authored by Peipei Shi

Since Specialization
Citations

This map shows the geographic impact of Peipei Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peipei Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peipei Shi more than expected).

Fields of papers citing papers by Peipei Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peipei Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peipei Shi. The network helps show where Peipei Shi may publish in the future.

Co-authorship network of co-authors of Peipei Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Peipei Shi. A scholar is included among the top collaborators of Peipei Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peipei Shi. Peipei Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Shengyun, Peipei Shi, Haizhou Li, et al.. (2025). NLRP3 Deficiency in Macrophages Ameliorates Gut Inflammation and Augments Treg Population In Vivo and In Vitro. Journal of Biochemical and Molecular Toxicology. 39(7). e70382–e70382.
2.
Yin, Sheng, Peipei Shi, Hua Li, et al.. (2025). Pathological and molecular insights into intravenous leiomyomatosis: an integrative multi-omics study. Journal of Translational Medicine. 23(1). 229–229.
3.
Wang, Qin, Peipei Shi, Jing Liu, et al.. (2023). Diagnostic value of serum CRP, PCT and IL-6 in children with nephrotic syndrome complicated by infection: a single center retrospective study. Pediatric Research. 95(3). 722–728. 3 indexed citations
4.
Wang, Qin, Peipei Shi, Jing Liu, et al.. (2023). Role of abnormal glycosylated IgA1 and interstitial transformation of glomerular endothelial cells in the development and progression of IgA nephropathy. ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics. 49(1). 54–54. 1 indexed citations
5.
Zheng, Yongbo, Na Zeng, Kai Yuan, et al.. (2023). Prevalence and risk factor for long COVID in children and adolescents: A meta-analysis and systematic review. Journal of Infection and Public Health. 16(5). 660–672. 72 indexed citations breakdown →
6.
Shi, Peipei, et al.. (2023). External validation of the pediatric International IgA Nephropathy Prediction Tool in a central China cohort. Clinical and Experimental Nephrology. 28(1). 59–66. 3 indexed citations
7.
8.
Gao, Wen, Haiyan Sun, Peipei Shi, et al.. (2022). SPP1 is a prognostic related biomarker and correlated with tumor-infiltrating immune cells in ovarian cancer. BMC Cancer. 22(1). 1367–1367. 33 indexed citations
9.
Wang, Qin, et al.. (2021). Impact of body mass index on primary immunoglobulin A nephropathy prognosis: a systematic review and meta-analysis. International Urology and Nephrology. 54(5). 1067–1078. 2 indexed citations
10.
Shi, Peipei, Chenchen Li, Xiaodan Wu, et al.. (2021). Continuous subcutaneous insulin infusion ameliorates bone structures and mechanical properties in type 2 diabetic rats by regulating bone remodeling. Bone. 153. 116101–116101. 11 indexed citations
11.
Liu, Yufeng, Jianjiang Zhang, W. F. Mader, et al.. (2021). The role of miR-199b-3p in regulating Nrf2 pathway by dihydromyricetin to alleviate septic acute kidney injury. Free Radical Research. 55(6). 634–644. 17 indexed citations
12.
Chen, Xuan, et al.. (2020). MiR-485-5p Promotes Neuron Survival through Mediating Rac1/Notch2 Signaling Pathway after Cerebral Ischemia/Reperfusion. Current Neurovascular Research. 17(3). 259–266. 14 indexed citations
13.
Qin, Peng, et al.. (2020). <p>LncRNA PVT1 Suppresses the Progression of Renal Fibrosis via Inactivation of TGF-β Signaling Pathway</p>. Drug Design Development and Therapy. Volume 14. 3547–3557. 19 indexed citations
14.
Zhu, Shengyun, Peipei Shi, Bin Pan, et al.. (2018). Loss of NLRP3 Function Alleviates Murine Hepatic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 24(12). 2409–2417. 11 indexed citations
15.
16.
17.
Clément-Duchêne, Christelle, Ronald B. Natale, Thierry Jahan, et al.. (2012). A phase II study of enzastaurin in combination with erlotinib in patients with previously treated advanced non-small cell lung cancer. Lung Cancer. 78(1). 57–62. 11 indexed citations
18.
Schwartzberg, Lee S., Róbert Hermann, Ian W. Flinn, et al.. (2012). Phase II Study of Enzastaurin in Patients with Follicular Lymphoma: Updated Final Clinical Results and Immunohistochemical Correlations. Blood. 120(21). 777–777. 4 indexed citations
19.
Ghobrial, Irene M., Nikhil C. Munshi, Brianna Harris, et al.. (2011). A phase I safety study of enzastaurin plus bortezomib in the treatment of relapsed or refractory multiple myeloma. American Journal of Hematology. 86(7). 573–578. 19 indexed citations
20.
Wang, Jian Z., Juong G. Rhee, Peipei Shi, Robert D. Stewart, & X. Allen Li. (2008). In vitrodetermination of radiation sensitivity parameters for DU-145 prostate cancer cells. International Journal of Radiation Biology. 84(6). 515–522. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne‐Marie Langevin Breakdown of academic impact, for papers by Márta Hegyi Breakdown of academic impact, for papers by Munveer S. Bhangoo Breakdown of academic impact, for papers by Lei Dong Breakdown of academic impact, for papers by Giulia Ferrarazzo Breakdown of academic impact, for papers by Reo Tanoshima Breakdown of academic impact, for papers by Janet Yoon Breakdown of academic impact, for papers by Kentaro Tsunamoto Breakdown of academic impact, for papers by Raees Tonse Breakdown of academic impact, for papers by Longkai Peng
Rankless by CCL
2026